Genericisation in cost-effectiveness analysis of cystic fibrosis medicines

Lancet. 2024 Jun 15;403(10444):2591-2592. doi: 10.1016/S0140-6736(24)00247-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aminophenols / economics
  • Aminophenols / therapeutic use
  • Aminopyridines / economics
  • Aminopyridines / therapeutic use
  • Benzodioxoles / economics
  • Benzodioxoles / therapeutic use
  • Cost-Benefit Analysis*
  • Cost-Effectiveness Analysis
  • Cystic Fibrosis* / drug therapy
  • Cystic Fibrosis* / economics
  • Drug Combinations
  • Drug Costs
  • Drugs, Generic* / economics
  • Humans
  • Quinolones / economics
  • Quinolones / therapeutic use

Substances

  • Drugs, Generic
  • Aminophenols
  • Benzodioxoles
  • Quinolones
  • Aminopyridines
  • Drug Combinations